Jiao S | Advanced Materials Engineering | Women Researcher Award

Posted on by sciencefather

Prof. Jiao S | Advanced Materials Engineering | Women Researcher Award

Chairman of the Department at Jilin university | China

Dr. Sun Jiao is an Associate Professor at the School of Basic Medical Sciences, Jilin University, specializing in nanomedicine, photo-responsive materials, and biomedical applications of functional nanocomposites. With over 15 years of research experience, she has made substantial contributions to the field of advanced materials for antibacterial therapy and cancer treatment.

👨‍🎓Profile

Scopus

🎓 Early Academic Pursuits

Dr. Sun’s academic foundation is firmly rooted in chemistry and physical sciences. She earned her B.Sc. in Applied Chemistry from Northeast Normal University (1998–2002), and proceeded to obtain her Ph.D. in Physical Chemistry from Jilin University (2002–2007), one of China’s leading institutions. Her doctoral research laid the groundwork for her future endeavors in chemical and biomedical innovation.

🧪 Professional Endeavors

After completing her Ph.D., Dr. Sun embarked on postdoctoral research at Xiamen University (2007–2010) and later at CNRS & University of Caen Normandy, France (2013–2014), where she deepened her expertise in catalysis and spectroscopy. She has since been serving at Jilin University, first as a Lecturer (2010–2016) and currently as an Associate Professor (2016–present).

🔬 Contributions and Research Focus On Advanced Materials Engineering

Dr. Sun Jiao’s research is centered on smart nanomaterials for antibacterial and cancer therapy. She has developed nanozymes, including ceria-based systems for wound healing, and Janus nanocomposites for targeted periodontitis therapy. Her work on lead-free perovskite nanocrystals also advances optoelectronic applications. Integrating chemistry, biomedical engineering, and materials science, her research drives innovation in photothermal, photodynamic, and chemo-responsive platforms, contributing to next-generation therapeutic technologies and multifunctional nanomedicine.

🌍 Impact and Influence

Her high-impact publications in prestigious journals such as Advanced Materials, Angewandte Chemie, Small, and Journal of Controlled Release speak volumes about her global academic influence. These works have established her as a respected figure in nanobiomedicine, particularly for bacterial biofilm treatment and perovskite-based optoelectronic devices.

🧠 Research Skills

Dr. Sun is highly skilled in nanoparticle synthesis and surface functionalization, with deep expertise in photothermal and photodynamic analysis for biomedical applications. She excels in material characterization techniques such as spectroscopy and microscopy, enabling detailed investigation of nanostructures. Her strength in interdisciplinary research project management, along with a strong record in grant acquisition and patent development, highlights her capabilities in translational research and applied innovation across chemistry, materials science, and biomedical engineering.

👩‍🏫 Teaching Experience

Dr. Sun has been actively involved in teaching and academic mentorship at Jilin University since 2010. Her promotion from Lecturer to Associate Professor reflects not only her academic achievements but also her commitment to education and student development in the fields of chemistry, biomedicine, and materials science.

🏅 Awards and Honors

  • 🥇 National First Prize (2023) from the Joint Meeting of National Demonstration Centers for Experimental Teaching in Higher Education for her project on cyanobacteria-based NIR-triggered photodynamic therapy for peri-implantitis.

  • 📜 Holder of three national patents related to antibacterial nanomaterials, cell microfluidics, and FAD inhibitors, showcasing both innovation and real-world application.

🔮 Legacy and Future Contributions

Dr. Sun Jiao is positioned to make even greater contributions in the next decade, particularly in translational nanomedicine, green chemistry, and smart therapeutic systems. Her interdisciplinary collaborations, ongoing NSFC and enterprise-funded projects, and leadership in industry-academic integration suggest a strong potential for international breakthroughs and technology transfer.

Publications Top Notes

IR820 Sensitized Ceria Nanozyme via PDA Bridging for Multifaceted Antibacterial Wound Healing Therapy

  • Authors: Akram Nasser Juaim, Jiao Sun, Ran Nie, Wen Li, Lina Ding, Kun Wang, Jing Zhou, Meiqi Li, Minghan Chi, Biao Dong, Manlin Qi, Lin Wang
    Journal: Small
    Year: 2025

Gold core@CeO₂ halfshell Janus nanocomposites catalyze targeted sulfate radical for periodontitis therapy

  • Authors: Sijia Li, Qihang Ding, Lingling Zhang, Fangyu Shi, Chengyu Liu, Tingxuan Li, Yujia Shi, Manlin Qi, Lin Wang, Biao Dong, Shuyan Song, Jiao Sun, Jong Seung Kim, Chunyan Li
    Journal: Journal of Controlled Release
    Year: 2024

Breaking Iron Homeostasis: Iron Capturing Nanocomposites for Combating Bacterial Biofilm

  • Authors: Wenyue Sun, Jiao Sun, Qihang Ding, Manlin Qi, Jing Zhou, Yujia Shi, Jia Liu, Miae Won, Xiaolin Sun, Xue Bai, Biao Dong, Jong Seung Kim, Lin Wang
    Journal: Angewandte Chemie International Edition
    Year: 2024

Efficient and Stable Multi-Color Emissions of the Coumarin Modified Cs₃LnCl₆ Lead-Free Perovskite Nanocrystals and LED Application

  • Authors: Liheng Sun, Biao Dong, Jiao Sun, Yiming Wang, Yuqi Wang, Songtao Hu, Bingshuai Zhou, Xue Bai, Lin Xu, Donglei Zhou, Hongwei Song
     Journal: Advanced Materials
     Year: 2024

A Novel Z-Scheme Heterostructured Bi₂S₃/Cu-TCPP Nanocomposite with Synergistically Enhanced Therapeutics against Bacterial Biofilm Infections in Periodontitis

  • Authors: Qingchao Kong, Manlin Qi, Wen Li, Yujia Shi, Jing Su, Shimeng Xiao, Jiao Sun, Xue Bai, Biao Dong, Lin Wang
    Journal: Small
    Year: 2023

 

 

Lakshmi Joshitha K | Wireless Networks | Best Researcher Award

Posted on by sciencefather

Dr. K. Lakshmi Joshitha | Wireless Networks | Best Researcher Award

Dr. K. Lakshmi Joshitha, Sri Sai Ram Engineering College, India

Dr. K. Lakshmi Joshitha is a Professor with 25+ years of experience in Wireless Sensor Networks, VLSI Design, Embedded Systems, and Robotics. She holds an M.E., Ph.D. and has published patents and research in esteemed journals. As an IEEE Fellow and research guide at Anna University, she has significantly contributed to academic innovation. Her work includes leading projects in AI and advanced manufacturing technology. Dr. Joshitha’s passion for mentorship and innovation drives her research career. 🌟📚💡

Bo Ling | Agricultural | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Bo Ling | Agricultural | Best Researcher Award

Assoc. Prof. Dr. Bo Ling, Northwest A&F University, China.

Dr. Ling Bo (👨‍🔬), an Associate Professor at Northwest A&F University, specializes in agri-food processing technologies using radio frequency, microwave, and ultrasound 🌾⚡. With a Ph.D. in Agricultural Mechanization Engineering, he has published in top journals 📚, holds national patents 🧪, and received a National Science & Technology Progress Award 🏆. He also serves on editorial boards of Q1 journals, showcasing his global academic leadership 🌍. His work promotes sustainable, efficient, and green food innovation. 🌱💡

🧠 Early Academic Pursuits

Ling Bo embarked on a strong academic path rooted in food science and agricultural engineering. 🎓 He obtained his Bachelor’s degree in Food Quality and Safety from Gansu Agricultural University (2005–2009), followed by a Master’s in Food Science from Southwest University (2009–2012). Eager to specialize further, he pursued a Ph.D. in Agricultural Mechanization Engineering at Northwest A&F University (2012–2016), demonstrating early dedication to interdisciplinary agricultural innovation. 🌱

💼 Professional Endeavors

Dr. Ling Bo’s academic career began at the College of Mechanical and Electronic Engineering, Northwest A&F University, where he served as a Lecturer from 2016 to 2019. In December 2019, he advanced to Associate Professor, a role he continues to hold, leading pioneering research and mentoring the next generation of agricultural engineers. 🏫 His postdoctoral work from 2016 to 2018 in Food Science and Engineering further solidified his scientific grounding. 🔬

🔬 Contributions and Research Focus On Agricultural 

Ling Bo’s research stands at the intersection of engineering and food science, focusing on emerging physical field-based technologies like radio frequency, microwave, and ultrasound. His work emphasizes sustainable valorization of agri-food by-products, efficient drying techniques, and eco-friendly disinfestation and pasteurization methods. 🌾 His innovative systems improve food processing quality, reduce energy use, and add value to agricultural waste—advancing the green food technology frontier. 🍎⚡

🌍 Impact and Influence

Ling Bo has significantly influenced agricultural food engineering through cutting-edge publications, patents, and funded research projects. His systems for solid-liquid extraction and fluid heating are poised to reshape post-harvest processing across China. His work on radio frequency heating technologies has applications in both industrial-scale food processing and traditional Chinese medicinal materials, bridging ancient knowledge with modern science. 🧪📈

📚 Academic Citations

Dr. Ling Bo has published extensively in peer-reviewed journals, including Food and Bioprocess Technology, Innovative Food Science and Emerging Technologies, and Food Research International. His papers have been widely cited for their methodological rigor and practical applicability in food engineering. 📖 His review on pectin extraction using physical fields is particularly acclaimed. ✍️

🏆 Awards and Honors

Dr. Ling Bo’s excellence has earned him national recognition, including the Science and Technology Progress Award (Second Prize) from the State Council of the People’s Republic of China in 2017 for innovations in dried nut processing technologies. 🏆 He also serves on the editorial boards of Food Physics and Food Quality and Safety (JCR Q1), underscoring his influence in academic publishing. 📰

🔮 Legacy and Future Contributions

Dr. Ling Bo is paving the way for a sustainable and technology-driven future in agri-food processing. His continued work promises advances in green energy applications, nutrient preservation, and agri-waste valorization. As a scholar, mentor, and innovator, his legacy lies in making food processing smarter, safer, and more sustainable. 🚜🌿 The coming years will likely see him lead transformative collaborations both nationally and internationally. 🌐✨

📚Publications Top Notes

📘 Recent advances in the drying of medicinal herb by novel physical field-based techniques: A review
Journal of Stored Products Research – 2025 🌿

🍴 Recent advances in food processing by radio frequency heating techniques: A review of equipment aspects
Journal of Food Engineering – 2023 ⚙️

🍊 Roles of physical fields in the extraction of pectin from plant food wastes and byproducts: A systematic review
Food Research International – 2023 🧪

🌾 Performance evaluation of the double screw conveyor in radio frequency systems: Heating uniformity and quality of granular foods
Innovative Food Science and Emerging Technologies – 2022 🔥

🍏 Radio frequency assisted extraction of pectin from apple pomace: Process optimization and comparison with microwave and conventional methods
Food Hydrocolloids – 2021 🍎

🌽 Recent developments in applications of radio frequency heating for improving safety and quality of food grains and their products: A review
Critical Reviews in Food Science and Nutrition – 2020 🌟

🍚 Effect of radio frequency treatment on functional, structural and thermal behaviors of protein isolates in rice bran
Food Chemistry – 2019 🧬

🌾 Radio-frequency treatment for stabilization of wheat germ: Storage stability and physicochemical properties
Innovative Food Science and Emerging Technologies – 2019 🧃

🌾 Radio-frequency treatment for stabilization of wheat germ: Dielectric properties and heating uniformity
Innovative Food Science and Emerging Technologies – 2018 ⚡

Lei Cao | Hematology | Best Research Article Award

Posted on by sciencefather

Dr. Lei Cao | Hematology | Best Research Article Award

Dr. Lei Cao, The First Affiliated Hospital of Nanjing Medical University, China.

Dr. Lei Cao 🎓, Deputy Chief Physician, Master’s Supervisor, and Lecturer at The First Affiliated Hospital of Nanjing Medical University, specializes in malignant lymphomas and lymphoproliferative disorders 🔬. She has led multiple national research projects, published in top-tier journals 📚, and received prestigious awards and scholarships 🏅. With a strong focus on individualized treatment and prognostic stratification, Dr. Cao is advancing cancer care and research globally 🌍.

🌟 Professional Profile

Orcid Profile

🧠 Early Academic Pursuits

Dr. Lei Cao began her academic journey with a passion for hematology and oncology, pursuing rigorous medical education that laid the foundation for her specialization in malignant lymphomas and lymphoproliferative disorders. Her early focus on precise prognostic stratification and individualized treatments set the tone for a career rooted in clinical excellence and scientific inquiry.

💼 Professional Endeavors

Currently serving as Deputy Chief Physician, Master’s Supervisor, and Lecturer at the First Affiliated Hospital of Nanjing Medical University, Dr. Cao is a dynamic force in clinical medicine and medical education. She is actively involved in mentoring graduate students while maintaining a busy clinical and research schedule.

🔬 Contributions and Research Focus On Hematology 

Dr. Cao’s research focuses on T-cell, B-cell, NK/T-cell, and Hodgkin lymphomas, with an emphasis on improving patient survival and quality of life through personalized medicine. She has led several national and institutional research projects, notably as Principal Investigator on prestigious grants such as the National Natural Science Foundation of China Youth Project and the Bethune Medical Science Research Foundation.

Her research outputs address topics like immunosuppressive microenvironments, hepatitis B reactivation in lymphoma patients, and novel chemotherapy strategies. She has authored multiple peer-reviewed SCI-indexed journal articles, furthering insights into the biology and treatment of hematologic malignancies

🌍 Impact and Influence

Dr. Cao’s work has directly contributed to clinical protocols, particularly in the treatment of indolent and relapsed lymphomas. Her clinical innovations and data-driven treatment strategies are helping to personalize therapies for patients across China. As a reviewer for journals such as Frontiers in Oncology and Cancer Medicine, she helps maintain the integrity of scientific research globally.

📚 Academic Citations

With a citation index of 419, her work demonstrates growing international recognition, showcasing the impact of her findings on clinical and academic communities alike.

🏆 Awards and Honors

Dr. Lei Cao’s accolades include:

  • 🥇 First Prize, 2022 Jiangsu Anti-Cancer Association

  • 🥉 Third Prize, 2023 Clinical Research Innovation Award, Jiangsu Ruihua Charity Foundation

  • 🌍 Jiangsu Government Study Abroad Scholarships (2020 & 2023)

  • 👩‍🔬 2019 CSCO 35 Under 35 Most Promising Young Oncologist

  • 🎓 Multiple National Scholarships

🧪 Patents and Publications

 

  • 📄 Patent: ZL202121517226.0 (National Utility Patent)

  • 📰 Authored numerous high-impact publications in journals such as Blood Cancer Journal, British Journal of Haematology, Annals of Medicine, and Cancer Science.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Lei Cao aims to refine stratification models, enhance targeted therapies, and further promote patient-centric care in hematologic malignancies. Her leadership, both in research and mentorship, continues to inspire a new generation of oncologists and researchers. Her future endeavors promise to deepen the scientific understanding of lymphoma biology and expand access to innovative treatments.

📚Publications Top Notes

📘 Title: Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients

📚 Journal: British Journal of Haematology
📅 Year: 2023
🧪🩸🛡️ (Oncology, Haematology, Immunity)

📘 Title: Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma

📚 Journal: Blood Cancer Journal
📅 Year: 2025
🧠🧬💉 (Oncology, Hematology, CNS)

 

Lei Cao | Hematology | Best Research Article Award

Posted on by sciencefather

Dr. Lei Cao | Hematology | Best Research Article Award

Dr. Lei Cao, The First Affiliated Hospital of Nanjing Medical University, China.

Dr. Lei Cao 🎓, Deputy Chief Physician, Master’s Supervisor, and Lecturer at The First Affiliated Hospital of Nanjing Medical University, specializes in malignant lymphomas and lymphoproliferative disorders 🔬. She has led multiple national research projects, published in top-tier journals 📚, and received prestigious awards and scholarships 🏅. With a strong focus on individualized treatment and prognostic stratification, Dr. Cao is advancing cancer care and research globally 🌍.

🌟 Professional Profile

Orcid Profile

🧠 Early Academic Pursuits

Dr. Lei Cao began her academic journey with a passion for hematology and oncology, pursuing rigorous medical education that laid the foundation for her specialization in malignant lymphomas and lymphoproliferative disorders. Her early focus on precise prognostic stratification and individualized treatments set the tone for a career rooted in clinical excellence and scientific inquiry.

💼 Professional Endeavors

Currently serving as Deputy Chief Physician, Master’s Supervisor, and Lecturer at the First Affiliated Hospital of Nanjing Medical University, Dr. Cao is a dynamic force in clinical medicine and medical education. She is actively involved in mentoring graduate students while maintaining a busy clinical and research schedule.

🔬 Contributions and Research Focus On Hematology 

Dr. Cao’s research focuses on T-cell, B-cell, NK/T-cell, and Hodgkin lymphomas, with an emphasis on improving patient survival and quality of life through personalized medicine. She has led several national and institutional research projects, notably as Principal Investigator on prestigious grants such as the National Natural Science Foundation of China Youth Project and the Bethune Medical Science Research Foundation.

Her research outputs address topics like immunosuppressive microenvironments, hepatitis B reactivation in lymphoma patients, and novel chemotherapy strategies. She has authored multiple peer-reviewed SCI-indexed journal articles, furthering insights into the biology and treatment of hematologic malignancies.

🌍 Impact and Influence

Dr. Cao’s work has directly contributed to clinical protocols, particularly in the treatment of indolent and relapsed lymphomas. Her clinical innovations and data-driven treatment strategies are helping to personalize therapies for patients across China. As a reviewer for journals such as Frontiers in Oncology and Cancer Medicine, she helps maintain the integrity of scientific research globally.

📚 Academic Citations

With a citation index of 419, her work demonstrates growing international recognition, showcasing the impact of her findings on clinical and academic communities alike.

🏆 Awards and Honors

Dr. Lei Cao’s accolades include:

  • 🥇 First Prize, 2022 Jiangsu Anti-Cancer Association

  • 🥉 Third Prize, 2023 Clinical Research Innovation Award, Jiangsu Ruihua Charity Foundation

  • 🌍 Jiangsu Government Study Abroad Scholarships (2020 & 2023)

  • 👩‍🔬 2019 CSCO 35 Under 35 Most Promising Young Oncologist

  • 🎓 Multiple National Scholarships

🧪 Patents and Publications

  • 📄 Patent: ZL202121517226.0 (National Utility Patent)

  • 📰 Authored numerous high-impact publications in journals such as Blood Cancer Journal, British Journal of Haematology, Annals of Medicine, and Cancer Science.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Lei Cao aims to refine stratification models, enhance targeted therapies, and further promote patient-centric care in hematologic malignancies. Her leadership, both in research and mentorship, continues to inspire a new generation of oncologists and researchers. Her future endeavors promise to deepen the scientific understanding of lymphoma biology and expand access to innovative treatments.

📚Publications Top Notes

📘 Title: Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients

📚 Journal: British Journal of Haematology
📅 Year: 2023
🧪🩸🛡️ (Oncology, Haematology, Immunity)

📘 Title: Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma

📚 Journal: Blood Cancer Journal
📅 Year: 2025
🧠🧬💉 (Oncology, Hematology, CNS)

 

Phetcharat Boonruamkaew | Neurophysiology | Best Researcher Award

Posted on by sciencefather

Dr. Phetcharat Boonruamkaew | Neurophysiology | Best Researcher Award

Dr. Phetcharat Boonruamkaew, School of Pharmacy/ Walailak University, Thailand.

🎓 Dr. Phetcharat Boonruamkaew is a Lecturer at the School of Pharmacy, with a Ph.D. in Physiology from Prince of Songkla University. Her expertise lies in neurophysiology, 🧠 oxidative stress, and neurodegenerative models. She has contributed significantly through her research, teaching, and international collaborations 🇯🇵. With multiple awards including the HEA Fellowship 🏅 and IBRO-SfN travel grants, Dr. Boonruamkaew continues to inspire in the field of neuroscience and pharmacology.📘🌿

🌟 Professional Profile

🧠 Early Academic Pursuits

Dr. Phetcharat Boonruamkaew’s academic journey reflects a deep-seated passion for biomedical sciences. 🎓 She began her higher education with a Bachelor’s degree in Physical Therapy (Second Class Honor) from Walailak University in 2009. Her pursuit of anatomical and physiological knowledge continued with an M.Sc. in Anatomy from Mahidol University in 2012, and she achieved the pinnacle of academic qualification with a Ph.D. in Physiology from Prince of Songkla University in 2016. Her doctoral research excellence was later recognized as the Excellent Ph.D. Dissertation by the university.

💼 Professional Endeavors

Dr. Boonruamkaew currently serves as a Lecturer at the School of Pharmacy, where she has been an integral part since 2017. Her global outlook on research was further enriched during her time as a Researcher at the University of Tsukuba, Japan in 2015, contributing to cutting-edge studies in neurodegeneration and oxidative stress.

🔬 Contributions and Research Focus On Neurophysiology 

With a strong foundation in neurophysiology, Dr. Boonruamkaew’s expertise spans oxidative stress markers, and animal models of neurodegenerative disorders 🧪. Her key research investigates the neuroprotective and pharmacological activities of natural extracts such as Passiflora edulis and Apium graveolens in mice models simulating Parkinson’s disease and Alzheimer’s pathology. She has also pioneered work on antioxidative nanoparticles for treating amyloid plaque formation.

🌍 Impact and Influence

Her work has significantly impacted the fields of alternative medicine, neurodegeneration research, and antioxidant therapy. 📊 Through innovative applications of plant-based compounds and nanoparticles, she has opened new avenues for therapeutic strategies in chronic neurodegenerative diseases. Dr. Boonruamkaew’s research findings have been presented across prestigious global platforms in USA, Japan, Iran, Denmark, Malaysia, and India, enhancing international collaborations and scientific exchange.

📚 Academic Citations

Dr. Boonruamkaew has co-authored numerous peer-reviewed journal articles, including publications in Scientific Reports, BMC Complementary and Alternative Medicine, and Oxidative Medicine and Cellular Longevity. 🧾 Her works, such as those exploring Apium graveolens and nanoparticle therapy, have contributed substantially to the academic discourse and are increasingly cited by fellow researchers worldwide.

🏅 Awards and Honors

Over the years, Dr. Boonruamkaew has garnered multiple prestigious recognitions, including:

  • Fellow of the Higher Education Academy (HEA), UK, 2019 🎖️

  • IBRO-SfN Travel Grant, USA, 2017

  • Excellent Ph.D. Dissertation Award, 2016 🧑‍🎓

  • Multiple full-grant scholarships from IBRO-APRC to attend international neuroscience schools and conferences in Iran, Malaysia, and India between 2013–2016.

🏛️ Legacy and Future Contributions

As an emerging leader in neuropharmacology and teaching, Dr. Boonruamkaew’s academic legacy lies in her integrative approach—combining natural medicine, oxidative stress modulation, and advanced drug delivery systems. 🌱🔬 Her continued engagement in undergraduate education and scientific mentorship ensures a lasting impact on future generations of pharmacists and researchers. With ongoing contributions to both academia and biomedical research, she stands as a beacon of innovation and dedication in the Thai and global scientific communities.

📚Publications Top Notes

  • 🧠 The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice
    📘 BMC Complementary and Alternative Medicine
    📅 2018 | 🔢 Citations: 68

  • 🧬 Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer’s disease
    📘 Scientific Reports
    📅 2017 | 🔢 Citations: 43

  • 😊 Apium graveolens extract influences mood and cognition in healthy mice
    📘 Journal of Natural Medicines
    📅 2017 | 🔢 Citations: 32

  • 😌 Anxiolytic and free radical scavenging potential of Chinese celery (Apium graveolens) extract in mice
    📘 Asian Pacific Journal of Tropical Biomedicine
    📅 2017 | 🔢 Citations: 27

  • 🛡️ Redox Nanoparticle Therapeutics for Acetaminophen‐Induced Hepatotoxicity in Mice
    📘 Oxidative Medicine and Cellular Longevity
    📅 2016 | 🔢 Citations: 20
    (Note: This article appears twice, once under Boonruamkaew and once under B. Phetcharat, likely a co-authorship or metadata duplication.)

  • 🥬 Celery
    📘 Nutritional Composition and Antioxidant Properties of Fruits and Vegetables
    📅 2020 | 🔢 Citations: 6

Zhengyuan Feng | Computer Vision | Best Researcher Award

Posted on by sciencefather

Mr. Zhengyuan Feng | Computer Vision | Best Researcher Award

Mr. Zhengyuan Feng, Shanghai Dianji University, China.

Zhengyuan Feng 🎓 is a graduate student at Shanghai Dianji University, specializing in Computer Vision and Artificial Intelligence 🤖. With strong skills in algorithms, programming, and system design, he developed a novel feature extraction method based on AGAST to enhance SLAM performance in weak-texture environments. Passionate about solving complex technical challenges, Zhengyuan is building a solid path toward future roles in technology R&D and engineering innovation 🚀.

🌟 Professional Profile

ORCID 

🧠 Early Academic Pursuits

Zhengyuan Feng began his academic journey with a deep interest in computing and technology. As a student at Shanghai Dianji University, he embraced computer science with a focus on foundational areas such as algorithms, programming, and system design. These early interests laid the groundwork for his specialization in forward-looking disciplines, including artificial intelligence and machine learning. His academic growth has been marked by consistent exploration of emerging technologies and a drive to solve real-world problems through innovative engineering solutions.

💼 Professional Endeavors

Although still a student, Feng has demonstrated professional-caliber thinking through his hands-on research and engineering practice. His ability to independently develop and optimize systems reflects a strong alignment with roles typically reserved for experienced engineers in technology R&D. While he has not yet participated in formal industry collaborations or consultancy projects, his approach to problem-solving and design mirrors industry standards and practices.

🔬 Contributions and Research Focus On Computer Vision  

Zhengyuan Feng’s research centers on Computer Vision and Artificial Intelligence, with a particular emphasis on Simultaneous Localization and Mapping (SLAM) systems. To overcome the limitations of traditional SLAM algorithms in weak-texture environments, he proposed two key innovations: an adaptive threshold feature extraction method based on AGAST and a multi-dimensional feature fusion-based loop closure detection algorithm. These techniques notably enhance the robustness and accuracy of SLAM performance under challenging conditions. His contributions reflect deep technical insight and creative application of AI methodologies to real-world computational challenges.

🌍 Impact and Influence

Although still early in his academic career, Feng’s innovations promise meaningful improvements in fields that rely on robust SLAM systems, such as robotics, autonomous vehicles, and augmented reality. His work not only bridges the gap between theory and application but also sets the stage for future integration of adaptive AI techniques in embedded systems and navigation technologies.

🏆 Awards and Honors

While no formal awards have been listed in the current application, Zhengyuan Feng is seeking recognition through the Best Researcher Award. His application is a testament to the innovation and promise he brings as a graduate researcher. This nomination itself underscores the scholarly merit and relevance of his contributions to advanced computing.

🔮 Legacy and Future Contributions

Zhengyuan Feng is poised to become a key contributor in the evolution of intelligent systems. His trajectory suggests a future filled with academic publications, technological breakthroughs, and industry collaborations. As he moves forward, his focus will likely deepen on enhancing human-machine interaction, improving real-time decision-making systems, and pushing the boundaries of what artificial intelligence can achieve in dynamic environments.

📚Publications Top Notes

Post-integration based point-line feature visual SLAM in low-texture environments

Scientific Reports, April 26, 2025
DOI: 10.1038/s41598-025-97250-6
Co-authors: Yanli Liu, Zhengyuan Feng, Heng Zhang, Wang Dong
Summary: This study introduces a novel visual SLAM approach that integrates point and line features to enhance performance in low-texture environments.

Abraham Teunissen | Immunology | Best Researcher Award

Posted on by sciencefather

Dr. Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen, Icahn school of medicine, United States.

Dr. Abraham J. P. Teunissen 🎓 is an Assistant Professor at the Biomedical Engineering and Imaging Institute, Icahn School of Medicine, New York 🗽. He leads groundbreaking research in nanomedicine, radiochemistry, and immunotherapy 🧬. With a Ph.D. in Molecular Engineering, he has authored high-impact studies and holds key patents. Dr. Teunissen mentors future scientists 👨‍🔬👩‍🔬 and champions diversity and inclusion. His work on trained immunity and advanced imaging technologies is shaping the future of personalized medicine 🌟.

🌟 Professional Profile

🎓Early Academic Pursuits 

Abraham J. P. Teunissen, Ph.D., embarked on his academic journey at Fontys University of Applied Science, earning a B.ASc in Organic Chemistry in 2011, where he developed supramolecular polymers for improved hemodialysis. He continued at Eindhoven University of Technology, securing an M.Sc. in Molecular Engineering (2013) and completing a Ph.D. (2017) focused on competing interactions in chemical reaction networks. His early research on biomimetic systems and chemical networks laid the foundation for a distinguished career in biomedical sciences.

🏢Professional Endeavors 

Dr. Teunissen’s professional journey showcases a trajectory of growth and leadership. He held appointments at the prestigious Icahn School of Medicine at Mount Sinai, progressing from Postdoctoral Scientist (2017) to Instructor (2019), and ultimately to Assistant Professor (2022). He also serves as the Director of Radiochemistry at the Biomedical Engineering and Imaging Institute. Beyond academia, he consulted for Trained Therapeutix Discovery, driving translational innovation from 2019 to 2021.

🔬Contributions and Research Focus On Immunology 

Dr. Teunissen has made notable contributions to nanomedicine, immunology, and molecular imaging. His research lab develops novel nanotherapies and imaging probes to modulate and monitor the immune system in various diseases — including cancer, cardiovascular disease, diabetes, and organ transplantation. His team’s work spans small and large animal models, advancing therapeutic strategies with clinical relevance. His radiochemistry facility supports diverse collaborations, innovating nanoparticle tracking and immune monitoring using immuno-PET technology.

🌎Impact and Influence 

The outcomes of Dr. Teunissen’s research have wide-reaching impacts. His lab’s pioneering work on trained immunity modulation has driven forward collaborations, clinical translation efforts, and even the founding of a biotech company, Trained Therapeutix Discovery. His immuno-PET technologies enhance understanding of disease mechanisms and inform therapeutic interventions, demonstrating translational significance from bench to bedside.

📚Academic Cites and High-Impact Publications 

Dr. Teunissen’s work has appeared in leading journals such as Cell, Nature Biomedical Engineering, Nature Nanotechnology, and Science Translational Medicine. His high citation count reflects the significance of his research, especially in trained immunity, nanomedicine, and molecular imaging fields. These citations highlight his contributions to both fundamental science and applied biomedical research.

🏆Awards and Honors 

While specific individual awards were not detailed, Dr. Teunissen’s achievements include serving as an ad-hoc NIH and American Cancer Society grant reviewer, organizing major scientific symposia, and designing graduate-level coursework. His leadership roles — like incident commander and scientific advisory organizer — reflect high institutional trust and professional recognition.

🔮Legacy and Future Contributions 

Dr. Teunissen’s legacy is rooted in scientific excellence, mentorship, and innovation. With an active lab mentoring a diverse group of postdocs, graduate, and premedical students, he is shaping the next generation of biomedical engineers and nanomedicine scientists. His future contributions are expected to further bridge fundamental science and clinical application, aiming to improve therapeutic outcomes for major diseases through immune modulation and advanced molecular imaging. His strong commitment to diversity, inclusion, and education ensures a lasting positive impact on both science and society.

📚Publications Top Notes

  • Development of Methods for the Determination of pKa Values
    📰 Analytical Chemistry Insights | 📑 483 citations | 📅 2013

  • Investigating Supramolecular Systems Using Förster Resonance Energy Transfer
    📰 Chemical Society Reviews | 📑 159 citations | 📅 2018

  • Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
    📰 Cell | 📑 145 citations | 📅 2020

  • Efficacy and Safety Assessment of a TRAF6-Targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-Human Primates
    📰 Nature Biomedical Engineering | 📑 128 citations | 📅 2018

  • End Groups of Functionalized Siloxane Oligomers Direct Block-Copolymeric or Liquid-Crystalline Self-Assembly Behavior
    📰 Journal of the American Chemical Society | 📑 110 citations | 📅 2016

  • Tumor Targeting by αvβ3-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
    📰 ACS Nano | 📑 93 citations | 📅 2020

  • Directing the Self‐Assembly Behaviour of Porphyrin‐Based Supramolecular Systems
    📰 Chemistry – A European Journal | 📑 82 citations | 📅 2017

  • Imaging-Assisted Nanoimmunotherapy for Atherosclerosis in Multiple Species
    📰 Science Translational Medicine | 📑 68 citations | 📅 2019

  • Prosaposin Mediates Inflammation in Atherosclerosis
    📰 Science Translational Medicine | 📑 65 citations | 📅 2021

  • Nuclear Imaging Approaches Facilitating Nanomedicine Translation
    📰 Advanced Drug Delivery Reviews | 📑 63 citations | 📅 2020

  • Probing Myeloid Cell Dynamics in Ischaemic Heart Disease by Nanotracer Hot-Spot Imaging
    📰 Nature Nanotechnology | 📑 61 citations | 📅 2020

  • Mechanically Induced Gelation of a Kinetically Trapped Supramolecular Polymer
    📰 Macromolecules | 📑 52 citations | 📅 2014

  • Imaging Cardiovascular and Lung Macrophages with the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs
    📰 Circulation: Cardiovascular Imaging | 📑 44 citations | 📅 2020

  • Resolving Sepsis-Induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells
    📰 Nature Biomedical Engineering | 📑 37 citations | 📅 2023

  • A Modular Approach Toward Producing Nanotherapeutics Targeting the Innate Immune System
    📰 Science Advances | 📑 35 citations | 📅 2021

  • An Iterative Sparse Deconvolution Method for Simultaneous Multicolor 19F‐MRI of Multiple Contrast Agents
    📰 Magnetic Resonance in Medicine | 📑 30 citations | 📅 2020

 

Chengqun Xu | Environmental | Best Researcher Award

Posted on by sciencefather

Dr. Chengqun Xu | Environmental | Best Researcher Award

Dr. Chengqun Xu, Wuyi University, China.

Dr. Chengqun Xu 🎓 is an Associate Professor at the School of Applied Physics and Materials, Wuyi University. He earned his Ph.D. in Physical Chemistry from South China University of Technology. His research focuses on photocatalysis, materials nanoarchitectonics, and green energy technologies 🌱. With multiple first-author publications in top-tier journals, he is recognized for his innovation and leadership in advanced materials science 🔬. Dr. Xu continues to make significant strides in sustainable research for global impact 🌍.

🌟 Professional Profile

Scopus Profile

🎓 Early Academic Pursuits

Dr. Chengqun Xu embarked on his academic journey with a Bachelor’s degree in Chemistry 🎓 from Anqing Normal University (2007–2011). Driven by a passion for deep scientific exploration, he pursued a Master’s degree in Physical Chemistry 🔬 at South China Normal University (2012–2015). Eager to further sharpen his research capabilities, Xu then earned his Ph.D. in Physical Chemistry 🧪 from South China University of Technology (2015–2018), laying a strong foundation for his future academic and research career.

💼 Professional Endeavors

Dr. Chengqun Xu began his career as a Lecturer 👨‍🏫 at the School of Applied Physics and Materials, Wuyi University (2019–2023). His outstanding contributions and commitment to academia led to his promotion as an Associate Professor 📚 in 2023 at the same institution. Additionally, he expanded his global experience by working at the International Center for Materials Nanoarchitectonics (NIMS), Japan 🇯🇵 during two distinct periods (2017–2018 and 2023–2024), engaging in advanced international collaborations.

🔬 Contributions and Research Focus On Environmental 

Dr. Xu’s research primarily revolves around photocatalytic materials, molecular engineering, and carbon nitride-based systems ☀️🧬. His focus is on enhancing photocatalytic hydrogen production, optimizing π-delocalization in g-C₃N₄, and developing direct Z-scheme photocatalytic systems. His projects delve into green light-driven catalysis and visible-light hydrogen evolution, aiming to solve global energy challenges sustainably 🌎.

🌐 Impact and Influence

Through his innovative work, Chengqun Xu has significantly impacted the field of environmental catalysis and renewable energy materials 🔥♻️. His advanced engineering of photocatalysts has set new benchmarks for efficiency, promoting cleaner energy generation and inspiring further research into sustainable technologies among peers and future scientists.

🏆 Awards and Honors

Dr. Chengqun Xu successfully completed the Guangdong Basic and Applied Basic Research Foundation Regional Joint Youth Fund Project 🌟, where he served as Principal Investigator. His outstanding project on regulating conjugation effects in g-C₃N₄ molecular structures received funding of 100,000 RMB, recognizing his pioneering contribution to molecular photocatalysis research.

📊Academic Cites

Dr. Xu’s research excellence is reflected in his publications in prestigious journals such as Applied Catalysis B: Environmental, Chemical Engineering Journal, ACS Applied Materials & Interfaces, and Journal of Materials Chemistry A 📖✨. His role as sole first author in multiple high-impact papers underlines his leadership in his field. His works continue to garner citations and influence researchers worldwide.

🚀 Legacy and Future Contributions

Dr. Chengqun Xu’s legacy lies in his molecular-level innovations for sustainable energy ⚡. As he continues his journey, Xu is poised to lead groundbreaking research projects, contribute to more international collaborations 🌍, and mentor the next generation of researchers. His work promises to pave the way for future technologies that bridge chemistry, materials science, and environmental sustainability.

📚Publications Top Notes 

📄 Title: Molten-salt assisted synthesis of polymeric carbon nitride-based photocatalyst for enhanced photocatalytic activity under green light irradiation
👥 Authors: Chengqun Xu; Haiyang Liu; Dongyu Wang; Dezhi Li; Ying Zhang; Xiaolu Liu; Jingyao Huang; Shengquan Wu; Donghua Fan; Hongguang Liu; Hui Pan
📰 Journal: Applied Catalysis B: Environmental
📅 Year: 2023

📄 Title: Direct Z-scheme construction of g-C₃N₄ quantum dots/TiO₂ nanoflakes for efficient photocatalysis
👥 Authors: Chengqun Xu; Dezhi Li; Xiaolu Liu; Renzhi Ma; Nobuyuki Sakai; Yuchen Yang; Shiyin Lin; Jiale Yang; Hui Pan; Janjer Huang; Takayoshi Sasaki
📰 Journal: Chemical Engineering Journal
📅 Year: 2021

📄 Title: Coordination of π-Delocalization in g-C₃N₄ for Efficient Photocatalytic Hydrogen Evolution under Visible Light
👥 Authors: Chengqun Xu; Xiaolu Liu; Dezhi Li; Zeyuan Chen; Jiale Yang; Janjer Huang; Hui Pan
📰 Journal: ACS Applied Materials & Interfaces
📅 Year: 2021

📄 Title: Molecular engineering for constructing a D–A system and enhancing delocalization in g-C₃N₄ with superior photocatalytic activity
👥 Authors: Chengqun Xu; Xiaolu Liu; Haiyang Liu; Dezhi Li; Yuchen Yang; Shiyin Lin; Donghua Fan; Hui Pan
📰 Journal: Journal of Materials Chemistry A
📅 Year: 2022

📄 Title: Molecular engineering of polymeric carbon nitride for photocatalytic hydrogen production with ultrahigh apparent quantum efficiency
👥 Authors: Haiyang Liu; Xiaolu Liu; Chengqun Xu; Dongyu Wang; Dezhi Li; Jingyao Huang; Shengquan Wu; Zhichun Wang; Hui Pan
📰 Journal: Journal of Materials Chemistry A
📅 Year: 2024

📄 Title: Molecular doping and molten-salt-assisted synthesis for a highly efficient polymeric carbon nitride-based photocatalyst with broad-spectrum optical responsiveness
👥 Authors: H. Liu, Yifan Chen, Chengqun Xu, Donghua Fan, Jinhua Ye
📰 Journal: Journal of Alloys and Compounds
📅 Year: 2025

 

Adem Melekoğlu | Cardiovascular | Academic Research and Development Award

Posted on by sciencefather

Dr. Adem Melekoğlu | Cardiovascular | Academic Research and Development Award

Dr. Adem Melekoğlu, Şişli Hamiiye Etfal Trining and Research Hospital, Turkey.

Dr. Adem Melekoğlu 🎓 is an Emergency Medicine Specialist at Şişli Hamidiye Etfal Training and Research Hospital, Turkey. With a medical degree from Cukurova University and a doctoral specialization in Emergency Medicine, he has made impactful contributions through extensive clinical research 🔬, focusing on acute care, cardiovascular emergencies, and COVID-19. Dr. Melekoğlu has actively participated in national and international congresses 🎤, sharing valuable insights. His commitment to academic research and development makes him a distinguished figure in emergency medicine 🚑.

🌟 Professional Profile

🎓 Early Academic Pursuits

Dr. Adem Melekoğlu began his medical journey with a solid academic foundation at Çukurova University, where he earned his medical degree in 2011. Demonstrating a strong passion for emergency care, he advanced his studies at Ankara Dışkapı Yıldırım Beyazıt Training and Research Hospital, completing his doctoral specialization in Emergency Medicine in 2016. His early education laid the groundwork for a focused and impactful career in clinical medicine and research.

💼 Professional Endeavors

Since 2016, Dr. Melekoğlu has been serving as an Emergency Medicine Specialist at the Şişli Hamidiye Etfal Training and Research Hospital under the Health Sciences University of Turkey. His role involves not only patient care in critical situations but also training, mentoring, and contributing to the development of emergency medical protocols and responses.

🔬 Contributions and Research Focus On Cardiovascular 

Dr. Melekoğlu has actively contributed to the evolving body of emergency medicine with a distinct focus on cardiovascular emergencies, COVID-19-related complications, toxicology, and respiratory disorders like COPD. His research portfolio includes over 20 clinical trials and case studies, where he has served as a responsible researcher, co-researcher, or instructor, reflecting his versatility in both clinical and academic settings. From investigating the efficacy of Esmolol and Nicardipine in ischemic stroke to exploring biomarkers in COVID-19, his work bridges critical gaps in real-time emergency care.

🌐 Impact and Influence

Dr. Melekoğlu’s research has been presented at leading national and international platforms, including the International Emergency Medicine Congress, Eurasian Congress on Emergency Medicine, and Young Academy of Cardiovascular Congress. His findings have enriched clinical understanding and influenced treatment strategies, particularly in emergency management of acute pulmonary embolism, ischemic strokes, and COVID-related cardiac issues.

🏆 Awards and Honors

Among the notable recognitions is his oral presentation at the 3rd International Emergency Medicine Congress (2023) on COPD Emergency Admissions, marking his presence as a scholarly voice in acute care research. His continuous involvement as a conference speaker and instructor further underscores his status in the academic community.

📊Academic Citations

While exact citation numbers are pending, the diversity and relevance of his studies suggest a growing academic footprint. His collaborative roles in widely referenced case reports and observational studies contribute to the expanding repository of emergency care literature in Turkey and globally.

🚀 Legacy and Future Contributions

With a career rooted in dedication, innovation, and lifesaving interventions, Dr. Adem Melekoğlu is poised to make enduring contributions to emergency medicine. His work not only saves lives but also educates future generations of emergency physicians. Looking ahead, his commitment to exploring inflammation indexes, clinical biomarkers, and innovative treatment protocols positions him as a forward-thinking leader in medical science.

📚Publications Top Notes 

🧪 Comparison of Esmolol and Nicardipine Treatment in Hypertensive Acute Ischemic Stroke Patients
Journal: Scientific Reports
Year: 2025
DOI: 10.1038/s41598-025-98699-1

💓 Relationship Between Shock Index, sPESI Score, and Right Ventricular Dysfunction in CTPA with Mortality in Patients Diagnosed with Acute PTE in the Emergency Department
Journal: Journal of Academic Research in Medicine
Year: 2023
DOI: 10.4274/jarem.galenos.2023.16769

🦠 Serum Endocan Levels as A Valuable Biomarker for Discrimination of Critical and Stable COVID-19 Patients
Journal: Bagcilar Medical Bulletin
Year: 2023
DOI: 10.4274/BMB.galenos.2023.2022-10-083

🧬 Evaluation of Laboratory Findings for Treating Acute Ischemic Stroke
Journal: Global Emergency and Critical Care
Year: 2023
DOI: 10.4274/globecc.galenos.2023.57966

🩸 Relationship Between Hematological Parameters and Mortality in Patients with Acute PTE
Journal: Global Emergency and Critical Care
Year: 2023
DOI: 10.4274/globecc.galenos.2023.00719

🌬️ Clinical Evaluation of Chronic Obstructive Pulmonary Disease Patients Hospitalized with COVID-19 Pneumonia
Journal: Indian Journal of Respiratory Care
Year: 2023
DOI: 10.5005/jp-journals-11010-1006